Robert Watson
About Robert Watson
Robert Watson serves as President of Destra Multi-Alternative Fund (DMA) since 2018; his birth year is 1965 . Over the past five years he has been Partner & Head of Investments at Destra Capital Management, Destra Capital Investments LLC and Destra Capital Advisors LLC (2021–present); previously he was Senior Managing Director and Investment Product Strategist at Destra Capital entities (2011–2020) . As President, he signs the Fund’s proxy materials and shareholder communications . The proxy does not disclose executive performance metrics (e.g., TSR, revenue or EBITDA growth) tied to his role; officers are not compensated by the Fund, limiting pay‑for‑performance visibility .
Past Roles
| Organization | Role | Years | Strategic impact |
|---|---|---|---|
| Destra Capital Management / Destra Capital Investments LLC / Destra Capital Advisors LLC | Senior Managing Director and Investment Product Strategist | 2011–2020 | Not disclosed in proxy |
| Destra Capital Management / Destra Capital Investments LLC / Destra Capital Advisors LLC | Partner & Head of Investments | 2021–present | Not disclosed in proxy |
| Destra Multi-Alternative Fund (DMA) | President | Since 2018 | Not disclosed in proxy |
External Roles
| Organization | Role | Years | Notes |
|---|---|---|---|
| Destra Capital Management / Destra Capital Investments LLC / Destra Capital Advisors LLC | Partner & Head of Investments | 2021–present | Principal occupation over past 5 years |
| Destra Capital entities | Senior Managing Director and Investment Product Strategist | 2011–2020 | Principal occupation prior to 2021 |
| Public company directorships | None disclosed | N/A | No public board roles disclosed for officers in DMA proxies |
Fixed Compensation
The Fund pays no salaries or compensation to officers; the Fund has no employees. Officers are provided by and employed by the Adviser (Destra Capital Advisors LLC) and are not paid by the Fund .
| Component | DMA Fund payment |
|---|---|
| Base salary | None paid by Fund |
| Target bonus % | None paid by Fund |
| Actual bonus | None paid by Fund |
| Cash retainer (officers) | None paid by Fund |
Note: Independent Trustees receive retainers ($39,000; Chairman $46,000), but this does not apply to officers .
Performance Compensation
No performance-based compensation (RSUs/PSUs/options) is paid by the Fund to officers; vesting schedules, metrics, and payouts are not applicable at the Fund level .
| Metric | Weighting | Target | Actual | Payout | Vesting |
|---|---|---|---|---|---|
| Not applicable—officers not compensated by Fund | N/A | N/A | N/A | N/A | N/A |
Equity Ownership & Alignment
- Officer beneficial ownership: DMA proxies provide beneficial ownership for significant shareholders but do not enumerate officer holdings; independent trustees held no Fund equity as of September 30, 2025 .
- Section 16/30(h) reporting: The Fund states applicable insider reporting was met in the last fiscal year; in 2023 initial Form 3 filings (including Robert Watson) were filed late, indicating a prior timeliness issue .
- Pledging/hedging: No officer pledging or hedging disclosure in the DMA proxy; only beneficial ownership of major holders is disclosed (e.g., Saba 24.94% of shares outstanding on the 2025 Record Date) .
| Item | Detail |
|---|---|
| Total beneficial ownership (Robert Watson) | Not disclosed in proxies |
| Ownership as % of shares outstanding | Not disclosed in proxies |
| Vested vs unvested shares | Not applicable/not disclosed at Fund level |
| Options (exercisable/unexercisable) | Not applicable/not disclosed at Fund level |
| Shares pledged as collateral | Not disclosed in proxies |
| Stock ownership guidelines (officers) | Not disclosed in proxies |
| Compliance status vs guidelines | Not disclosed in proxies |
Employment Terms
- Employment agreement, severance, change-of-control: No officer employment contracts, severance or change‑of‑control terms are disclosed at the Fund level; officers are not compensated by the Fund .
- Non‑compete, non‑solicit, garden leave, consulting: Not disclosed in DMA proxies .
- Start date in role: President since 2018 .
Investment Implications
- Pay-for-performance analysis is constrained: The Fund does not pay or disclose officer compensation, equity awards, or performance metrics for officers; thus alignment, vesting pressure, and incentive levers cannot be assessed at the Fund level .
- Governance/activism backdrop is material: Saba Capital Management beneficially owned 24.94% of shares as of the 2025 Record Date; this concentration can affect outcomes on board elections, strategic actions around the Fund’s scheduled termination in 2027, and overall governance dynamics .
- Compliance signal: A late Form 3 initial filing for Robert Watson in 2023 suggests prior reporting timeliness issues, though subsequent proxies state insider reporting requirements were met in the last fiscal year; monitor future filings for drift in compliance quality .
- Trading cues: With officer incentives undisclosed at the Fund level, signals are more likely to arise from shareholder activism and corporate actions than insider selling/vesting; watch proxy and 13D/13G updates from control/activist holders for catalysts .